WP
KRTX

Woodline Partners’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Woodline Partners’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-357,473
Closed -$113M – 667
2023
Q4 		$113M Buy
357,473
+334,751
+1,473% +$65.1M 1.23% 9
2023
Q3 		$3.84M Sell
22,722
-27,378
-55% -$5.15M 0.05% 340
2023
Q2 		$10.9M Buy
+50,100
New +$10.7M 0.13% 199
2022
Q4 		– Sell
-14,585
Closed -$3.28M – 883
2022
Q3 		$3.28M Sell
14,585
-132,150
-90% -$26.7M 0.05% 370
2022
Q2 		$18.6M Buy
146,735
+60,745
+71% +$6.98M 0.29% 110
2022
Q1 		$10.9M Buy
85,990
+69,226
+413% +$7.79M 0.18% 165
2021
Q4 		$2.2M Buy
16,764
+6,096
+57% +$788K 0.03% 404
2021
Q3 		$1.3M Hold
10,668
– – 0.02% 480
2021
Q2 		$1.22M Hold
10,668
– – 0.02% 417
2021
Q1 		$1.28M Buy
+10,668
New +$1.21M 0.03% 347

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Woodline Partners's KRTX Position: Q1 2024 in Review

Woodline Partners sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 357,473 shares — an estimated $113M sold.

Woodline Partners first reported a position in KRTX in Q1 2021 and held it in 10 quarters. The position peaked at $113M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Woodline Partners reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Woodline Partners sold 357,473 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $113M.
  • Woodline Partners first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • Woodline Partners's Karuna Therapeutics, Inc. Common Stock position peaked at $113M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Woodline Partners's 13F filing for Q1 2024, filed 15 May 2024.